Whilst the negative EBITDA is dissapointing, the surge in revenue is encouraging for what lies ahead.
What is very encouraging is that H1 revenue of 2.2m has lifted to 3.9m in HY2, which is a very solid half given that the business historically has a H1 seasonal bias.
Whilst the negative EBITDA is dissapointing, the surge in...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $22.41M | |||
| Open | High | Low | Value | Volume |
| 3.2¢ | 3.2¢ | 3.1¢ | $14.75K | 461.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 799316 | 3.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 917481 | 1 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| NOV (ASX) Chart |
